The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preclinical efficacy of copanlisib in cetuximab sensitive and resistant tumors of HNSCC.
 
Konrad Friedrich Klinghammer
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono
 
Oliver Politz
Employment - Bayer
Patents, Royalties, Other Intellectual Property - Bayer
Travel, Accommodations, Expenses - Bayer
 
Theresa Eder
No Relationships to Disclose
 
Raik Otto
No Relationships to Disclose
 
Jan D Raguse
Consulting or Advisory Role - Merck; Sanofi
Research Funding - Merck; Sanofi
Travel, Accommodations, Expenses - KLS Martin
 
Jens Hoffmann
Employment - EPO Berlin GmbH
Stock and Other Ownership Interests - EPO Berlin GmbH
Patents, Royalties, Other Intellectual Property - Bayer
 
Ulrich Keilholz
Honoraria - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; pfizer
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck Serono; MSD Oncology; Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Merck Serono; MSD Oncology